We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Breastfeeding Reduces Maternal CVD Health Risk

By HospiMedica International staff writers
Posted on 01 Feb 2022
Women who breastfed their children are less likely to develop cardiovascular disease (CVD) or stroke later on in life, according to a new study.

Researchers at the Medical University of Innsbruck (I-MED; Austria), the University of Bristol (United Kingdom), and other institution conducted a meta-analysis of eight relevant prospective studies conducted between 1986 and 2009 (in Australia, China, Norway, Japan, and the United States), involving 1,192,700 parous women (mean age 51.3 years), on average 24.6 years after their first birth. More...
Of these, 982,566 (82%) reported having ever breastfed, with the average total time of breastfeeding 15.6 months.

The results revealed that over an average follow-up period of 10 years, women who breastfed at some time in their life were 14% less likely to develop coronary heart disease (CHD); 12% less likely to suffer strokes; and 17% less likely to die from CVD. In all, women who breastfed for 12 months or longer had an overall 11% decreased risk of developing CVD, with no notable differences in CVD risk among women of different ages or based on the number of pregnancies. The study was published on January 11, 2022, in Journal of the American Heart Association (JAHA).

“It's important for women to be aware of the benefits of breastfeeding for their babies' health and also their own personal health,” said senior author professor of clinical epidemiology Peter Willeit, MD, PhD, of I-MED. “Moreover, these findings from high-quality studies conducted around the world highlight the need to encourage and support breastfeeding, such as breastfeeding-friendly work environments, and breastfeeding education and programs for families before and after giving birth.”

The World Health Organization recommends breastfeeding exclusively for the first six months of life. Even after the introduction of foods at six months, continued breastfeeding is recommended until at least one to two years of age. But only 38% of infants are breastfed on a global level, and only about 13% in the United States. Short term benefits for the mother include less blood loss, better uterus shrinkage, weight loss, and reduced postpartum depression. Long term benefits include decreased risk for breast cancer, CVD, and rheumatoid arthritis.

Related Links:
Medical University of Innsbruck
University of Bristol



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Critical Care Cart
Avalo
New
Infusion System
SIGMA Spectrum
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.